Sanofi

• 12/9/2024

  Novavax Revamps Business: Sells Czech Facility for $200M, Shifts Focus to Vaccine Pipeline

• 10/23/2024

  Merck’s RSV Breakthrough: Experimental Treatment Shields Infants

• 

  10/3/2024

  **Novavax Struggles with Unstable Revenue Growth**